Herbal formulation clinical trial on Cognitive adult patient
- Conditions
- Congenital malformation of brain,unspecified,
- Registration Number
- CTRI/2020/02/023297
- Lead Sponsor
- Botanic Healthcare Pvt Ltd
- Brief Summary
Earlier clinical studies using Nutraceuticalingredients of herbal origin have demonstrated significant improvement insymptoms of CognitionBased on the existing information wehypothesized that Ashwagandha supplemented for 56 days would provide aremarkable improvement of cognition.
Cognition is defined as ‘the mental action orprocess of acquiring knowledge and understanding through thought, experience,and the senses. Cognition is the mental processes relating to the input andstorage of information and how that information is then used to guide yourbehavior. It is in essence, the ability to perceive and react, process andunderstand, store and retrieve information, make decisions and produceappropriate responses. The modern word ‘cognition’ actually has its roots backto Latin, the word ‘cognoscere’ which is to ‘get to know’. With that in mind,cognitive functioning is therefore critical for day-to-day life, governing ourthoughts and actions. We need cognition to help us understand information aboutthe world around us and interact safely with our environment, as the sensoryinformation we receive is vast and complicated: cognition is needed to distillall this information down to its essentials
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 30
- 1.Both male and female subjects aged between 40-75 years with a complaint of memory impairment for at least one year without any major cognitive deficit.
- 2.Subjects who are willing to sign ICF.
1.Subjects with Psychiatric disorders 2.Subjects with alcohol consumption 3.Subjects with any organ system infection in past 30 days 4.Subjects with severe cognitive problems like dementia, function disability, post 5.vascular cerebral symptoms or with any neurological problems.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the efficacy and safety of Ashwagandha in subjects with cognitive impairment Day 0 Day 28 and Day 56
- Secondary Outcome Measures
Name Time Method 1.Adverse events (AEs), frequency and severity. 2.Number of subjects who discontinue study due to adverse events
Trial Locations
- Locations (1)
Sri venkateshwara Hospitals
🇮🇳Bangalore, KARNATAKA, India
Sri venkateshwara Hospitals🇮🇳Bangalore, KARNATAKA, IndiaDrPoorna prasadPrincipal investigator9481594148shettyshospital@gmail.com